AbbVie Inc. (NYSE:ABBV)

Total assets exhibited a generally declining trend over the five-year period. Initial values decreased from 2021 to 2023, followed by modest increases in 2024, and a further decrease in 2025. Adjusted total assets mirrored this pattern, though the magnitude of the changes differed.

Overall Trend

Both total assets and adjusted total assets demonstrate a net decrease from 2021 to 2025. Total assets decreased from US$146,529 million to US$133,960 million, representing a decline of approximately 8.6%. Adjusted total assets experienced a more substantial decrease, falling from US$144,255 million to US$127,856 million, a reduction of roughly 11.4%.

Year-over-Year Changes

From 2021 to 2022, total assets decreased by US$7,724 million, while adjusted total assets decreased by US$8,470 million. The decline continued from 2022 to 2023, with total assets decreasing by US$3,994 million and adjusted total assets decreasing by US$6,829 million. A slight recovery occurred between 2023 and 2024, with total assets increasing by US$450 million and adjusted total assets increasing by US$579 million. However, this was followed by a decrease in 2025, with total assets falling by US$1,191 million and adjusted total assets decreasing by US$614 million.

Discrepancy Between Metrics

The difference between total assets and adjusted total assets varied over the period. In 2021, adjusted total assets were US$2,274 million lower than total assets. This difference widened to US$3,020 million in 2022, then to US$5,755 million in 2023. It narrowed slightly to US$5,626 million in 2024, and further to US$6,104 million in 2025. The consistent negative difference suggests that adjustments consistently reduce the reported value of total assets.

The consistent adjustments to total assets warrant further investigation to understand the nature of these adjustments and their impact on the company’s financial position. The overall downward trend in both metrics suggests a potential contraction of the asset base, which could be due to various factors such as asset sales, write-downs, or changes in accounting policies.

Total liabilities exhibited fluctuations over the five-year period. Initially decreasing from 2021 to 2022, they subsequently increased through 2025. Adjusted total liabilities mirrored this pattern, though the magnitude of change differed. A consistent pattern emerges where adjusted total liabilities are lower than reported total liabilities across all observed periods.

Overall Trend

From 2021 to 2022, both total and adjusted liabilities decreased. Total liabilities decreased by approximately 7.2%, while adjusted liabilities saw a more substantial decrease of roughly 7.4%. Following 2022, both metrics increased annually through 2025. The increase from 2022 to 2025 for total liabilities was approximately 12.5%, and for adjusted liabilities, it was approximately 12.9%.

Magnitude of Adjustment

The difference between total liabilities and adjusted total liabilities remained relatively consistent throughout the period. In 2021, the adjustment amounted to US$3,297 million. This difference fluctuated slightly, reaching US$2,473 million in 2022, US$2,191 million in 2023, US$2,815 million in 2024, and US$2,703 million in 2025. This suggests a systematic, recurring adjustment is being applied.

Year-over-Year Changes

The largest year-over-year increase in total liabilities occurred between 2024 and 2025, at approximately 4.1%. The largest year-over-year increase in adjusted total liabilities also occurred between 2024 and 2025, at approximately 4.2%. The most significant decrease in both metrics was observed between 2021 and 2022.

The consistent difference between reported and adjusted total liabilities warrants further investigation to understand the nature of the adjustments being made. The increasing trend in both metrics from 2022 onward should be monitored to assess potential impacts on financial leverage and solvency.

Stockholders’ equity exhibited a volatile pattern over the five-year period. Initially, an increase was observed, followed by a substantial decline culminating in a deficit by the end of 2025. The adjusted total equity mirrored this trend, though with differing magnitudes and timing of changes.

Overall Equity Trend

Reported stockholders’ equity increased from US$15,408 million in 2021 to US$17,254 million in 2022, representing a growth of approximately 11.9%. However, a significant decrease followed, with equity falling to US$10,360 million in 2023, US$3,325 million in 2024, and ultimately resulting in a deficit of US$3,270 million in 2025. This represents a cumulative decline of over 100% from the 2022 peak.

Adjusted Equity Trend

Adjusted total equity showed a more moderate initial increase, moving from US$16,459 million in 2021 to US$16,740 million in 2022. A substantial decline began in 2023, reaching US$6,833 million, and continued through 2024 to US$553 million. Similar to stockholders’ equity, adjusted total equity also transitioned into a deficit by 2025, reaching US$6,629 million. The rate of decline appears to accelerate in the later years.

Relationship Between Equity Measures

The difference between stockholders’ equity and adjusted total equity remained relatively consistent in 2021 and 2022, at approximately US$1,051 million. However, the divergence widened considerably from 2023 onwards. The adjusted equity consistently exceeded the reported equity until 2024, at which point both measures began to approach deficit territory. By 2025, the adjusted equity deficit was larger in absolute value than the reported equity deficit, indicating that adjustments were exacerbating the overall equity position.

The substantial declines in both equity measures, particularly the transition to deficits by 2025, warrant further investigation to understand the underlying causes. The increasing difference between the two equity measures suggests that the adjustments being made are having a material and increasingly negative impact on the reported financial position.

An examination of the financial information reveals trends in reported and adjusted capital structures over a five-year period. Total reported debt decreased from 2021 to 2022, then continued to decline modestly through 2023, before increasing in both 2024 and 2025. Stockholders’ equity exhibited an initial increase between 2021 and 2022, followed by a substantial decline through 2025, ultimately resulting in a deficit. Consequently, total reported capital decreased from 2021 to 2023, stabilized in 2024, and then decreased again in 2025.

Debt Trends

Reported total debt began at US$76,684 million in 2021 and reached US$63,271 million in 2022, representing a decrease of approximately 17.5%. The decline continued to US$59,385 million in 2023, but then reversed, increasing to US$67,144 million in 2024 and US$67,496 million in 2025. Adjusted total debt mirrored this pattern, starting at US$77,575 million in 2021 and following a similar trajectory to the reported figures.

Equity Trends

Stockholders’ equity increased from US$15,408 million in 2021 to US$17,254 million in 2022. However, a significant decrease was observed in subsequent years, falling to US$10,360 million in 2023, US$3,325 million in 2024, and ultimately reaching a deficit of US$3,270 million in 2025. Adjusted total equity followed a similar pattern, though the magnitude of the decline differed, ending in a larger deficit of US$6,629 million in 2025.

Capital Structure Changes

Total reported capital decreased from US$92,092 million in 2021 to US$69,745 million in 2023, before stabilizing at US$70,469 million in 2024 and decreasing to US$64,226 million in 2025. Adjusted total capital exhibited a similar trend, beginning at US$94,034 million in 2021 and declining to US$61,750 million in 2025. The adjusted figures consistently show a slightly higher total capital amount than the reported figures.

The substantial decline in equity, coupled with the relatively stable debt levels in the later years, suggests a shift in the capital structure towards greater reliance on debt financing. The emergence of a deficit in stockholders’ equity by 2025, under both reported and adjusted calculations, warrants further investigation.

Net earnings attributable to AbbVie Inc. demonstrated initial growth followed by a substantial decline. Reported net earnings increased from US$11,542 million in 2021 to US$11,836 million in 2022, before experiencing a significant decrease to US$4,863 million in 2023. This downward trend continued into 2024 with net earnings reaching US$4,278 million, and remained relatively stable at US$4,226 million in 2025.

Adjusted net earnings exhibited a different pattern. While initially decreasing from US$10,680 million in 2021 to US$10,609 million in 2022, adjusted net earnings then fell sharply to US$1,834 million in 2023. A recovery was observed in 2024, with adjusted net earnings increasing to US$3,214 million, and further growth occurred in 2025, reaching US$4,600 million.

Relationship between Reported and Adjusted Earnings

The difference between net earnings attributable to AbbVie Inc. and adjusted net earnings widened considerably in 2023. This suggests the presence of significant items impacting reported earnings that are being excluded in the adjusted figure. The gap narrowed in 2024 and 2025 as adjusted earnings increased while reported earnings remained relatively flat.

Trends in Adjusted Earnings

Adjusted net earnings experienced a pronounced recovery from the low point in 2023. The increase from US$1,834 million in 2023 to US$4,600 million in 2025 indicates a substantial improvement in underlying business performance, or a reduction in the impact of non-recurring items being excluded from the adjusted calculation.

Discrepancy Analysis

The substantial divergence between the trends in reported and adjusted net earnings warrants further investigation. Understanding the nature of the adjustments made to arrive at the adjusted figures is crucial for assessing the sustainability of the company’s earnings and the quality of its reported results. The magnitude of the adjustments in 2023, in particular, requires detailed scrutiny.

Overall, the financial information indicates a period of volatility in reported earnings, coupled with a recovery in adjusted earnings following a significant decline. The adjustments to reported income appear to be material and are driving the differing trends observed.